HOME >> BIOLOGY >> NEWS
Promising anti-TB compound finally can be synthesized with ease

BUFFALO, N.Y. -- An efficient new strategy for synthesizing a natural marine product, which shows promising anti-tuberculosis activity but cannot be efficiently synthesized using conventional chemistry, is being reported by University at Buffalo organic chemists online on Feb. 10 in Angewandte Chemie International Edition.

The UB researchers' method synthesizes the compound in days rather than months, requires fewer steps and is capable of producing gram quantities.

The UB chemists describe the direct synthesis in the laboratory of the natural product isolated from the Pseudopterogorgia corals. They now are applying the synthesis method to other members of this class of compounds called diterpenes, some of which also have activity against TB and are potential anti-inflammatory and anticancer agents.

"We're poised now to make them all and to develop new analogs as potential medications," said Huw Davies, Ph.D., Larkin Professor of Organic Chemistry at UB and co-author.

Once thought to be nearly eliminated, tuberculosis is again among the world's most-deadly infectious diseases, killing between 2 million and 3 million people each year.

Its reemergence has been triggered partly by AIDS, which makes an individual 30 times more likely to develop TB, and by multidrug resistance caused by difficulties in getting patients to comply with long treatment regimens.

Davies explained that the family of marine compounds called diterpenes was discovered and demonstrated to have anti-TB activity in 2000, but as with most natural products, so little could be extracted from the marine organism that full biological evaluation was not possible.

To circumvent the problem, chemists have concentrated their efforts on producing the compounds in the laboratory.

Davies explained that the compounds have proven remarkably difficult to synthesize not because they're so complex, but because
'"/>

Contact: Ellen Goldbaum
goldbaum@buffalo.edu
716-645-5000 x1415
University at Buffalo
10-Feb-2005


Page: 1 2

Related biology news :

1. Promising protein may prevent eye damage in premature babies
2. Tailored treatments: Promising designer drug provides new insight into cancer biology
3. Promising antiobesity drug fails to produce clinically meaningful weight loss
4. Promising preclinical results with live attenuated H5N1 vaccines
5. Promising new research on hereditary diseases
6. Promising cell protein may play role in infection and dry eye
7. Promising results in the battle against incurable ALS muscle disease
8. Promising new preventative treatment option for population of men at high risk of prostate cancer
9. A compound from olive-pomace oil gets 80 percent slowing down of HIV spread
10. New compound effectively treats fungal infections
11. Natural compound and exercise boost memory in mice

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/2/2019)... ... ... In this podcast, Smith spoke about the history of his career and ... Beyond the Lab Podcast is an interview series initiated by Vanderbilt University School of ... biomedical field — and in these interviews, the alumni discuss the different facets, challenges ...
(Date:10/30/2019)... , ... October 30, 2019 , ... ... the Farm Credit Knowledge Center in which participants will learn about precision agriculture ... practice relating to these technologies. , Participants will have the opportunity to ...
(Date:10/30/2019)... ... October 30, 2019 , ... ... bioactivity that are encoded by the ordering of monomer residues into specific ... of the sidechain attachment to the backbone amide-nitrogen atoms. They are resistant ...
Breaking Biology News(10 mins):
(Date:11/12/2019)... ... November 12, 2019 , ... ... biopharmaceutical R&D, today announced that Immatics Biotechnologies , a clinical-stage biopharmaceutical ... to streamline their R&D operations related to the discovery and development ...
(Date:11/6/2019)... ... , ... Diversified Technologies, Inc. has introduced a PEF production system ... improve processing. , The DTI Industrial PEF Unit can pre-treat whole pieces of fruits ... by up to 50% and achieve up to an 80% reduction of drying energy. ...
(Date:11/2/2019)... ... October 31, 2019 , ... A clinical trial usually ... other: study managers, principal investigators, supply chain managers, manufacturers, IRT, CRAs and so ... of the latest data, potentially leading to patient risk. , By having a ...
(Date:10/29/2019)... ... October 28, 2019 , ... CaroGen Corporation , a ... , Professor Jack R Wands, MD, of Brown University , ... Professor Gil Mor, MD, PhD, of Wayne State University, formerly a professor ...
Breaking Biology Technology:
Cached News: